Catalyst squares up to FDA over rival drug approvalCatalyst Pharma is suing the FDA over its approval of a potential rival to its rare disease therapy Share XCatalyst squares up to FDA over rival drug approvalhttps://pharmaphorum.com/news/catalyst-squares-fda-rival-drug-approval/
